161 related articles for article (PubMed ID: 12011757)
21. [Central stimulants in the treatment of children with ADHD: unknown long-term effect and uncertain pharmacological documentation].
Zetterström R
Lakartidningen; 2002 Feb; 99(7):677-80. PubMed ID: 11887717
[No Abstract] [Full Text] [Related]
22. ADHD, methylphenidate and driving: does some legislation endanger public health?
Verster JC; Cox DJ
J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623
[No Abstract] [Full Text] [Related]
23. An ADHD 6-year-old child ultrarapid metabolizer for CYP2D6.
Bonnet-Brilhault F; Broly F; Blanc R; Furet Y; Barthélémy C; Paintaud G
J Clin Psychopharmacol; 2006 Aug; 26(4):442-4. PubMed ID: 16855474
[No Abstract] [Full Text] [Related]
24. Sustained-release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children.
Prescrire Int; 2004 Dec; 13(74):203-6. PubMed ID: 15612099
[TBL] [Abstract][Full Text] [Related]
25. Central auditory processing disorder and ADHD.
Jerome L
J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):399-400. PubMed ID: 10761339
[No Abstract] [Full Text] [Related]
26. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
27. [Attention deficit hyperactivity disorder in children].
Bervoets L
J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
[No Abstract] [Full Text] [Related]
28. Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
Quinn D; Bode T; Reiz JL; Donnelly GA; Darke AC
J Clin Pharmacol; 2007 Jun; 47(6):760-6. PubMed ID: 17395894
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological management of treatment-induced insomnia in ADHD.
Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
[No Abstract] [Full Text] [Related]
30. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
31. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
Kollins SH
J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
[TBL] [Abstract][Full Text] [Related]
32. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
33. The answerable question and a hierarchy of evidence.
Hamilton J
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):596-600. PubMed ID: 15908843
[No Abstract] [Full Text] [Related]
34. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
Gadow KD; Sverd J
Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
[No Abstract] [Full Text] [Related]
35. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
Taéron C
Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855
[No Abstract] [Full Text] [Related]
36. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.
Adler LA; Spencer T; McGough JJ; Jiang H; Muniz R
J Atten Disord; 2009 Mar; 12(5):449-59. PubMed ID: 19218542
[TBL] [Abstract][Full Text] [Related]
37. Dexmethylphenidate--Novartis/Celgene. Focalin, D-MPH, D-methylphenidate hydrochloride, D-methylphenidate, dexmethylphenidate, dexmethylphenidate hydrochloride.
Drugs R D; 2002; 3(4):279-82. PubMed ID: 12455205
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.
van der Feltz-Cornelis CM; Aldenkamp AP
Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592
[TBL] [Abstract][Full Text] [Related]
39. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
[TBL] [Abstract][Full Text] [Related]
40. [The use of methylphenidate in children with ADHD].
Lauth B
Laeknabladid; 2007 Dec; 93(12):823. PubMed ID: 18057471
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
